Ownership history in Portman Ltd · 2 quarters on record
This page tracks every 13F SEC filing in which Portman Ltd reported a position in VERA THERAPEUTICS (VERA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q3 | UNCHANGED | 32,795 | — | 0% | 3.62% | $1.4M | $44.20 |
| 2024 Q2 | INITIATED | 32,795 | — | — | 4.48% | $1.2M | — |
As of 2025 Q4 — sorted by position size